28.04.2010 • NewsDow ChemicalBilanz

Dow Chemical Profit, Revenue Spike

Dow Chemical posted a better-than-expected first-quarter profit on Wednesday as pricing, volume and sales spiked.

Net income rose to $466 million, or 41 cents per share, from $24 million, or 3 cents per share, a year earlier.

Excluding costs related to the 2009 acquisition of rival Rohm & Haas and restructuring, Dow earned 43 cents per share. By that measure, analysts expected earnings of 30 cents, according to Thomson Reuters I/B/E/S. Revenue rose 48.4% to $13.42 billion. Analysts expected $12.93 billion. Midland, Mich.-based Dow bought rival Rohm & Haas last April in a deal that sharply leveraged its balance sheet. Since then, the company has been selling off assets to repay the loan.

Dow peer DuPont said on Tuesday that first-quarter profit more than doubled.

Company

The Dow Chemical Company

100 Larkin Center
48674 Midland

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.